First trial for potential Covid-19 drug shows it has no effect
by Sarah Boseley Health editor from Science | The Guardian on (#52JS6)
WHO draft put online states remdesivir does not benefit severe coronavirus patients
Coronavirus latest: at a glance
Remdesivir, a drug thought to be one of the best prospects for treating Covid-19, failed to have any effect in the first full trial, it has been revealed.
The drug is in short supply globally because of the excitement it has generated. It is one of the drugs Donald Trump claimed was "promising".
Continue reading...